Renaissance Technologies LLC Grows Stake in Bicycle Therapeutics plc - MarketBeat
BCYC Stock | USD 20.54 0.28 1.38% |
About 53% of Bicycle Therapeutics' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Bicycle Therapeutics suggests that some traders are interested. The current market sentiment, together with Bicycle Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Bicycle Therapeutics stock news signals to limit their universe of possible portfolio assets.
Bicycle |
Renaissance Technologies LLC Grows Stake in Bicycle Therapeutics plc MarketBeat
Read at news.google.com
Bicycle Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Bicycle Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bicycle Therapeutics Fundamental Analysis
We analyze Bicycle Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bicycle Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bicycle Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Bicycle Therapeutics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Bicycle Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bicycle Therapeutics stock to make a market-neutral strategy. Peer analysis of Bicycle Therapeutics could also be used in its relative valuation, which is a method of valuing Bicycle Therapeutics by comparing valuation metrics with similar companies.
Peers
Bicycle Therapeutics Related Equities
TNYA | Tenaya Therapeutics | 10.19 | ||||
CCCC | C4 Therapeutics | 5.99 | ||||
MLYS | Mineralys Therapeutics, | 5.22 | ||||
ANAB | AnaptysBio | 5.20 | ||||
ORIC | Oric Pharmaceuticals | 5.15 | ||||
KROS | Keros Therapeutics | 3.86 | ||||
CGEM | Cullinan Oncology | 2.62 | ||||
MRUS | Merus BV | 2.55 | ||||
SEER | Seer | 2.10 | ||||
ACRV | Acrivon Therapeutics, | 1.71 | ||||
GLUE | Monte Rosa | 1.68 | ||||
STOK | Stoke Therapeutics | 1.42 | ||||
INBX | Inhibrx | 0.72 | ||||
IDYA | Ideaya Biosciences | 0.71 | ||||
MGTX | MeiraGTx Holdings | 0.17 | ||||
ADAG | Adagene | 0.00 | ||||
ANEB | Anebulo Pharmaceuticals | 2.67 | ||||
IGMS | IGM Biosciences | 9.01 | ||||
IMTXW | Immatics Biotechnologies | 13.04 |
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |